| 2025-12-10 |
详情>>
内部人交易：
McCabe Michael I共交易2笔
|
| 2025-11-06 |
详情>>
股本变动：
变动后总股本11825.80万股
变动原因 ▼▲
- 原因：
- From June 30, 2025 to September 30, 2025
Exchange of Class B, Class C and Class D units for Class A common stock and redemption of corresponding Class B common stock
|
| 2025-11-06 |
详情>>
业绩披露：
2026年中报每股收益-5.17美元,归母净利润-4.05亿美元,同比去年增长-1406.74%
|
| 2025-11-06 |
财报披露：
美东时间 2025-11-06 盘后发布财报
|
| 2025-08-07 |
详情>>
业绩披露：
2026年一季报每股收益-0.49美元,归母净利润-3842.4万美元,同比去年增长-388.3%
|
| 2025-07-25 |
股东大会：
将于2025-09-09召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification (“Proposal 1”);
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2026 (“Proposal 2”);
3.To approve, on a non-binding and advisory basis, the compensation of our named executive officers (“Proposal 3” or “Say-on-Pay”);
4.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law (“Proposal 4” or the “Exculpation Amendment Proposal”);
5.To approve amendments to the Company’s Amended and Restated Certificate of Incorporation to remove obsolete provisions and make certain other clarifying, technical and conforming changes (“Proposal 5” or the “Clean-Up Amendments Proposal”);
6.To transact any other business that may be properly presented at the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-05-23 |
详情>>
业绩披露：
2025年年报每股收益-2.52美元,归母净利润-1.8亿美元,同比去年增长-409.11%
|
| 2025-05-23 |
详情>>
业绩披露：
2023年年报每股收益-0.3美元,归母净利润-1839.8万美元,同比去年增长-109.49%
|
| 2025-02-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.32美元,归母净利润-1.61亿美元,同比去年增长-690.64%
|
| 2024-11-07 |
详情>>
业绩披露：
2025年中报每股收益0.46美元,归母净利润3096.00万美元,同比去年增长-34.81%
|
| 2024-08-08 |
详情>>
业绩披露：
2025年一季报每股收益0.20美元,归母净利润1332.80万美元,同比去年增长-37.34%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年一季报每股收益0.34美元,归母净利润2126.90万美元,同比去年增长292.65%
|
| 2024-07-29 |
股东大会：
将于2024-09-10召开股东大会
会议内容 ▼▲
- 1.To elect the five director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification;
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2025;
3.To approve, on a non-binding and advisory basis, the compensation of our named executive officers (“Say-on-Pay”);
4.To approve, for purposes of complying with Nasdaq Listing Rule 5635, the issuance of shares of the Company’s Class A common stock pursuant to the terms of the Option Agreement, dated November 2, 2022 (the “Option Agreement”), between the Company and the other parties thereto (“Proposal 4” or the “Nasdaq Proposal”);
5.To transact any other business that may be properly presented at the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-05-24 |
详情>>
业绩披露：
2024年年报每股收益0.91美元,归母净利润5809.10万美元,同比去年增长415.75%
|
| 2024-03-27 |
股东大会：
将于2024-05-13召开股东大会
会议内容 ▼▲
- 1.To approve, for purposes of complying with NASDAQ Listing Rule 5635, the issuance of shares of the Company’s Class A common stock issuable pursuant to the terms of the Transaction Agreements, each dated February 7, 2024 (the “Transaction Agreements”), between the Company and the other parties thereto, or related exchange agreement (“Proposal 1” or the “Nasdaq Proposal”);
2.To transact other such business as may properly come before the Special Meeting or any adjournment or postponement thereof.
|
| 2024-02-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.43美元,归母净利润2726.80万美元,同比去年增长157.77%
|
| 2023-11-07 |
详情>>
业绩披露：
2024年中报每股收益0.76美元,归母净利润4749.40万美元,同比去年增长217.97%
|
| 2023-07-25 |
股东大会：
将于2023-09-13召开股东大会
会议内容 ▼▲
- 1.To elect the three director nominees named in the proxy statement as Class III directors of the Company, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification (Proposal 1);
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2024 (Proposal 2);
3.To approve, on a non-binding and advisory basis, the compensation of our named executive officers (“Say-on-Pay”);
4.To approve the StepStone Group Inc. 2023 Employee Stock Purchase Plan;
5.To transact any other business that may be properly presented at the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-07-28 |
股东大会：
将于2022-09-14召开股东大会
会议内容 ▼▲
- 1.To elect the four director nominees named in the proxy statement as Class II directors of the Company, each to serve for a three-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification (Proposal 1);
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2023 (Proposal 2);
3.To conduct a non-binding and advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers (“Say-on-Frequency”);
4.To transact any other business that may be properly presented at the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-28 |
股东大会：
将于2021-09-24召开股东大会
会议内容 ▼▲
- 1.To elect the two director nominees named in the proxy statement as Class I directors of the Company, each to serve for a three-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification (Proposal 1);
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2022 (Proposal 2);
3.To transact any other business that may be properly presented at the Annual Meeting or any adjournment or postponement thereof.
|